MR-guidance in clinical reality: current treatment challenges and future perspectives

S Corradini, F Alongi, N Andratschke, C Belka… - Radiation …, 2019 - Springer
Abstract Magnetic Resonance-guided radiotherapy (MRgRT) marks the beginning of a new
era. MR is a versatile and suitable imaging modality for radiotherapy, as it enables direct …

Normal tissue constraints for abdominal and thoracic stereotactic body radiotherapy

EL Pollom, AL Chin, M Diehn, BW Loo… - Seminars in radiation …, 2017 - Elsevier
Although stereotactic body radiotherapy (SBRT) or stereotactic ablative radiotherapy has
become an established standard of care for the treatment of a variety of malignancies, our …

[HTML][HTML] ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)

F Cardoso, A Costa, L Norton, E Senkus, M Aapro… - The Breast, 2014 - Elsevier
Author links open overlay panel F. Cardoso a, A. Costa bc, L. Norton d, E. Senkus e, M.
Aapro f, F. André g, CH Barrios h, J. Bergh i, L. Biganzoli j, KL Blackwell k, MJ Cardoso l, T …

Non–small cell lung cancer, version 1.2015

DS Ettinger, DE Wood, W Akerley… - Journal of the National …, 2014 - jnccn.org
This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)
for Non-Small Cell Lung Cancer (NSCLC) focuses on the principles of radiation therapy …

Association of long-term outcomes and survival with multidisciplinary salvage treatment for local and regional recurrence after stereotactic ablative radiotherapy for …

ED Brooks, B Sun, L Feng, V Verma, L Zhao… - JAMA network …, 2018 - jamanetwork.com
Importance Stereotactic ablative radiotherapy (SABR) is first-line treatment for patients with
early-stage non–small cell lung cancer (NSCLC) who cannot undergo surgery. However, up …

High-dose re-irradiation following radical radiotherapy for non-small-cell lung cancer

D De Ruysscher, C Faivre-Finn, C Le Pechoux… - The Lancet …, 2014 - thelancet.com
As the prognosis of lung cancer patients improves, more patients are at risk of developing
local recurrence or a new primary tumour in previously irradiated areas. Technological …

Repeat stereotactic body radiotherapy (SBRT) for local recurrence of non-small cell lung cancer and lung metastasis after first SBRT

Y Ogawa, Y Shibamoto, C Hashizume, T Kondo… - Radiation …, 2018 - Springer
Background This study evaluated the safety and efficacy of repeat SBRT for local recurrence
of stage I non-small-cell lung cancer (NSCLC) and solitary lung metastasis. Methods Thirty …

[HTML][HTML] GOECP/SEOR radiotheraphy guidelines for non-small-cell lung cancer

NR De Dios, A Navarro-Martin, C Cigarral… - World journal of …, 2022 - ncbi.nlm.nih.gov
Non-small cell lung cancer (NSCLC) is a heterogeneous disease accounting for
approximately 85% of all lung cancers. Only 17% of patients are diagnosed at an early …

Stereotactic body radiotherapy (SBRT) for multiple pulmonary oligometastases: Analysis of number and timing of repeat SBRT as impact factors on treatment safety …

RJ Klement, J Hoerner-Rieber, S Adebahr… - Radiotherapy and …, 2018 - Elsevier
Background Stereotactic body radiotherapy (SBRT) for oligometastatic disease is
characterized by an excellent safety profile; however, experiences are mostly based on …

[HTML][HTML] Re-irradiation in the thorax–An analysis of efficacy and safety based on accumulated EQD2 doses

C Schröder, I Stiefel, S Tanadini-Lang, I Pytko… - Radiotherapy and …, 2020 - Elsevier
Introduction Thoracic re-irradiation remains a challenge regarding the balance of local
efficacy and acceptable toxicities. In this retrospective analysis we analyzed dosimetrical …